Related Experiment Videos
Atypical antipsychotics in older adults
Y C Chan1, S F Pariser, G Neufeld
1Department of Psychiatry, Ohio State University, Columbus 43210-1250, USA.
Pharmacotherapy
|July 23, 1999
Summary
Atypical antipsychotics are effective for older adults with psychotic symptoms, but more research is needed due to age-related factors and limited elderly-specific studies. Careful consideration of comorbidities and side effects is crucial for safe and effective treatment.
Area of Science:
- Geriatric Psychiatry
- Clinical Pharmacology
- Psychopharmacology
Background:
- Psychotic symptoms are prevalent in older adults, often linked to diverse psychiatric and medical conditions.
- Treatment with antipsychotic drugs is complicated in the elderly by comorbidities, side effect risks, and age-related physiological changes.
- Current knowledge on antipsychotic use in older adults relies heavily on studies of younger populations or small-sample elderly studies.
Purpose of the Study:
- To review psychiatric and medical conditions associated with psychotic symptoms in older adults.
- To discuss the benefits of antipsychotic treatment in this demographic.
- To highlight the need for more robust research on antipsychotic safety and efficacy in the elderly.
Main Methods:
- Review of existing literature on psychotic symptoms in older adults.
- Analysis of the role of antipsychotic medications, particularly atypical antipsychotics.
- Examination of challenges and considerations in treating elderly patients with psychotic disorders.
Main Results:
- Atypical antipsychotics demonstrate superior safety and efficacy, establishing them as first-line agents for schizophrenia and other psychotic disorders in older adults.
- Established uses include schizophrenia, schizoaffective disorders, delusional disorder, and mood disorders with psychotic features.
- Significant gaps exist in well-designed, placebo-controlled studies specifically in the elderly population.
Conclusions:
- Atypical antipsychotics offer significant benefits for older adults experiencing psychotic symptoms.
- Further well-designed studies are essential to optimize the safety, efficacy, and dosing of these agents in geriatric populations.
- Comprehensive management requires careful consideration of comorbid medical conditions and age-specific pharmacokinetic and pharmacodynamic changes.